Navigation Links
Bend Research Named Large Distinguished Business of the Year by Bend Chamber of Commerce Membership
Date:6/29/2011

BEND, Ore., June 29, 2011 /PRNewswire-USNewswire/ -- Bend Research Inc. (www.bendresearch.com), a leading independent drug-formulation development and manufacturing company, has been named Large Distinguished Business of the Year by the Bend Chamber of Commerce membership.

The award was announced at the Chamber's annual SAGE Awards banquet in late May.

According to the Bend Chamber, the annual award recognizes the large business among the Bend Chamber membership that has "…a reputation for providing outstanding products and/or services to their customers."

The Chamber noted that Bend Research is a "…cornerstone of Central Oregon's high-tech industry, taking pride in improving human health through innovation as well as contributing to the next generation of scientists."

"We're very honored to receive this award from the Chamber," said Rod Ray, president and chief executive officer of Bend Research Inc. "Our Central Oregon roots are a big part of what this company is all about, so this recognition means a lot to us."

The SAGE Awards is a competitive process. Businesses are nominated and then voted on by the Bend Chamber membership. Other nominees in the large business category were Eberhard's Dairy Products, family-owned and operated since 1951; and Tomco Electric Inc., established in 1973.

The Bend Chamber is one of the largest and most active chambers in Oregon, representing 1,200 businesses with more than 23,000 employees. In addition to acknowledging a distinguished large business, the chamber also recognized Donner Flowers as the Small Distinguished Business of the Year; Saving Grace as the Outstanding Organization of the Year; and Oran Teater, business leader and former mayor of Bend, as Citizen of the Year.

About Bend Research Inc.

For more than 30 years, Bend Research has worked with clients to create value by advancing new medicines that improve human health and to solve their most difficult scientific and technical problems. This success is based on the company's ability to develop, advance, and commercialize pharmaceutical technologies. The firm's innovative drug-delivery solutions grow from a solid base of scientific and engineering fundamental understanding.

Bend Research provides formulation and dosage-form support, assists in process development and optimization, manufactures clinical-trial quantities of drug candidates in its cGMP facilities, and advances promising drug candidates from conception through commercialization. Bend Research is a leader in novel formulations, including solubilization technologies such as spray-dried dispersions and hot-melt extrusion formulations, as well as controlled-release, inhalation, and biotherapeutics technologies.

Bend Research has more than 200 employees based in four state-of-the-art facilities in Bend, Oregon, USA. For more information about Bend Research and the SAGE award, please contact Phoenix Ivers via email at Phoenix.Ivers@BendResearch.com or phone at 541-382-4100.


'/>"/>
SOURCE Bend Research Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Napoleone Ferrara Wins 2011 Dr. Paul Janssen Award for Biomedical Research
2. Advocates, 150 Children With Type 1 Diabetes Urge FDA to Enable Critical Research on Life-Saving Artificial Pancreas to Move Forward
3. Cepheid Appoints Vice President of Infectious Disease Research & Development
4. Study Identifies Large Concentration of Contract Research Assets in Kansas City Region
5. AlphaDetail, Healthcare Market Research Specialist, Named to the Honomichl Top 50
6. Research Finds Greater Focus on Self-Care Would Save Patients and U.S. Healthcare System Over $5 Billion Annually
7. Research Led by Clinical Nurse Specialists Reconfirms Reliability of Temporal Artery Thermometry
8. Sanofi Enters Into Research Collaboration With Biopharmaceutical Company Audion Therapeutics to Develop Potential Treatments for Hearing Loss
9. ViaCyte Names Michael Scott Vice President, Device Research & Development
10. Research 2.0 Updates Coverage of Viral Genetics with Research Report Focused on VG Energy
11. Best of ASCO Features Two Studies Led by US Oncology Research Affiliated Physicians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... ... Quality metrics are proliferating in cancer care, and are derived from many of ... beholder, according to experts who offered insights and commentary in the current issue of ... full issue, click here . , For the American Society of Clinical Oncology ...
(Date:6/26/2016)... ... ... a legally blind and certified personal trainer is helping to develop a weight loss fitness ... to fix the two major problems leading the fitness industry today:, , ... They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
Breaking Medicine News(10 mins):